|
Variables
|
Midazolam n = 140
|
Non-midazolam n = 192
|
p value
|
|---|
|
Age, years
|
67.0 ± 1.0
|
66.6 ± 0.9
|
0.761
|
|
Male, n(%)
|
96(68.5)
|
134(69.7)
|
0.182
|
|
Hypertension, n(%)
|
24(17.1)
|
25(13.0)
|
0.296
|
|
Scr, mg/dl
|
1.5 ± 0.1
|
1.3 ± 0.1
|
0.209
|
|
MI
| | |
0.578
|
|
NSTEMI, n(%)
|
41(29.3)
|
49(25.5)
| |
|
AWSTEMI, n(%)
|
39(27.9)
|
63(32.8)
| |
|
NAWSTEMI, n(%)
|
60(42.9)
|
80(41.7)
| |
|
Beta-blocker, n(%)
|
109(77.9)
|
160(83.3)
|
0.209
|
|
Stain, n(%)
|
79(56.4)
|
125(65.1)
|
0.109
|
|
Vasopressor, n(%)
|
113(80.7)
|
150(78.1)
|
0.566
|
|
Revascularization, n(%)
|
82(58.6)
|
129(67.2)
|
0.107
|
|
Clinicals outcomes
| | | |
|
Mechanical ventilation time, hours
|
103.2 ± 10.1
|
49.5 ± 6.0
|
0.000
|
|
CCU time, days
|
10.1 ± 0.9
|
6.1 ± 0.5
|
0.000
|
|
CCU mortality, n(%)
|
41(29.3)
|
34(17.7)
|
0.013
|
|
Hospital mortality, n(%)
|
45(32.1)
|
37(19.3)
|
0.007
|
|
28-days mortality, n(%)
|
54(38.6)
|
43(22.4)
|
0.001
|
- Abbreviation as in Tables 1 and 3
